 |
 |
|
 |
|
Accession |
Disease |
Description |
Year |
Source |
RNA-Seq |
Count |
Biomarkers |
|
GSE117064 |
Stroke |
Serum miRNA-based risk prediction for stroke |
2018 |
Serum |
N |
1785 |
 |
|
GSE120584 |
Alzheimer's disease |
Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data |
2018 |
Serum |
N |
1601 |
 |
|
GSE139031 |
Glioma |
Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients with Diffuse Glioma |
2019 |
Serum |
N |
580 |
 |
|
GSE150693 |
Alzheimer's disease |
Prognosis prediction model for Alzheimer’s disease conversion from mild cognitive impairment by integrative analysis of multi-omics data |
2020 |
Serum |
N |
197 |
|
|
GSE140069 |
Creutzfeldt-Jakob disease |
A blood microRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis and rate of progression |
2019 |
Blood |
Y |
107 |
|
|
GSE46579 |
Alzheimer's disease |
A blood based 12-miRNA signature of Alzheimer patients |
2013 |
Blood |
N |
70 |
|
|
GSE42657 |
Brain tumor |
MicroRNA expression profiles for paediatric brain tumours |
2015 |
Tissue |
N |
64 |
|
|
GSE89596 |
Autism |
MicroRNA biomarkers in blood for Autism spectrum disorder |
2016 |
Blood |
N |
60 |
|
|
GSE52917 |
ALS |
Early pre-symptomatic and progressive signatures of non-coding RNAs in ALS patients and mutation carriers |
2013 |
Serum |
N |
53 |
|
|
GSE90828 |
Alzheimer's disease |
Plasma microRNA biomarker detection for mild cognitive impairment using differential correlation analysis |
2016 |
Plasma |
N |
52 |
|
|
GSE59286 |
Autism |
Regulation of gene expression change in autism by microRNA [miRNA-seq] |
2014 |
Tissue |
Y |
45 |
|
|
GSE17846 |
Multiple Sclerosis |
miRNA Profiling from total blood of Multiple Sclerosis and control samples |
2009 |
Blood |
N |
41 |
|
|
GSE39644 |
ALS |
Amyotrophic lateral sclerosis |
2012 |
Blood |
Y |
24 |
|
|
GSE77667 |
Parkinson's disease |
Expression miRNA data from human postmortem putamen samples measured using the NanoString nCounter platform |
2016 |
Tissue |
Y |
24 |
|
|
GSE43592 |
Multiple Sclerosis |
MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS) |
2013 |
Blood |
N |
20 |
|
|
GSE157239 |
Alzheimer's disease |
Profiling of post-mortem brain microRNA in Alzheimer’s disease |
2020 |
Tissue |
N |
16 |
|
|
E-MTAB-9140 |
ALS |
miRNome profiling of sporadic ALS patients |
2021 |
Tissue |
N |
15 |
|
|
E-MTAB-8283 |
Alzheimer's disease |
miRNA PCR Array of cortex tissue from Alzheimer disease (AD), high pathological control (HPC) and normal (CTL)subjects |
2019 |
Tissue |
N |
15 |
|
|
GSE21086 |
Autism |
Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders (ASD) by microRNA expression profiling of lymphoblastoid cell lines |
2010 |
Blood |
N |
14 |
|
|
GSE38385 |
Parkinson's disease |
MicroRNA (miRNA) expression profiling of blood leukocytes of Parkinson's disease (PD) patients pre- and post-deep brain stimulation treatment and of healthy control volunteers |
2012 |
Blood |
N |
13 |
|
|
GSE48552 |
Alzheimer's disease |
Alteration of the microRNA network during the progression of Alzheimer’s disease |
2013 |
Tissue |
Y |
12 |
|
|
GSE147232 |
Alzheimer's disease |
microRNA microarray profile in the plasma of mild cognitive impairment due to Alzheimer's disease |
2020 |
Plasma |
N |
10 |
|
|
E-MTAB-10779 |
Parkinson's disease |
Profiling of differentially expressed microRNAs in saliva of Parkinson’s disease patients |
2021 |
Saliva |
N |
10 |
|
|
GSE16759 |
Alzheimer's disease |
mRNA and miRNA expression in parietal lobe cortex in Alzheimer's disease |
2009 |
Tissue |
N |
8 |
|
|
GSE182910 |
Alzheimer's disease |
Identification of LncRNAs Differentially Expressed in the Serum of Alzheimer’s patients |
2021 |
Saliva |
N |
6 |
|
|
|
|
|
|
|
|
|